vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and Waterstone Financial, Inc. (WSBF). Click either name above to swap in a different company.
Waterstone Financial, Inc. is the larger business by last-quarter revenue ($37.2M vs $21.2M, roughly 1.8× Autolus Therapeutics plc). Waterstone Financial, Inc. produced more free cash flow last quarter ($23.0M vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
Waterstone Financial, Inc. is a U.S. bank holding company headquartered in Wisconsin. It offers retail and commercial banking services, residential mortgages, and wealth management solutions, primarily serving consumers and small to medium-sized businesses across the U.S. Midwest region.
AUTL vs WSBF — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $37.2M |
| Net Profit | $-79.1M | — |
| Gross Margin | — | — |
| Operating Margin | -337.9% | 27.0% |
| Net Margin | -373.3% | — |
| Revenue YoY | — | 16.7% |
| Net Profit YoY | 3.6% | — |
| EPS (diluted) | $-0.30 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $37.2M | ||
| Q3 25 | $21.2M | $37.0M | ||
| Q2 25 | $20.9M | $38.0M | ||
| Q1 25 | $9.0M | $29.7M | ||
| Q4 24 | — | $31.8M | ||
| Q3 24 | $0 | $34.1M | ||
| Q2 24 | $0 | $37.2M | ||
| Q1 24 | $10.1M | $32.4M |
| Q4 25 | — | — | ||
| Q3 25 | $-79.1M | $7.9M | ||
| Q2 25 | $-47.9M | $7.7M | ||
| Q1 25 | $-70.2M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-82.1M | $4.7M | ||
| Q2 24 | $-58.3M | $5.7M | ||
| Q1 24 | $-52.7M | $3.0M |
| Q4 25 | — | 27.0% | ||
| Q3 25 | -337.9% | 26.6% | ||
| Q2 25 | -292.6% | 25.4% | ||
| Q1 25 | -726.3% | 13.1% | ||
| Q4 24 | — | 19.5% | ||
| Q3 24 | — | 17.3% | ||
| Q2 24 | — | 19.2% | ||
| Q1 24 | -384.1% | 14.7% |
| Q4 25 | — | — | ||
| Q3 25 | -373.3% | 21.4% | ||
| Q2 25 | -229.0% | 20.3% | ||
| Q1 25 | -781.1% | 10.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 13.9% | ||
| Q2 24 | — | 15.4% | ||
| Q1 24 | -522.1% | 9.4% |
| Q4 25 | — | $0.43 | ||
| Q3 25 | $-0.30 | $0.45 | ||
| Q2 25 | $-0.18 | $0.43 | ||
| Q1 25 | $-0.26 | $0.17 | ||
| Q4 24 | — | $0.28 | ||
| Q3 24 | $-0.31 | $0.26 | ||
| Q2 24 | $-0.22 | $0.31 | ||
| Q1 24 | $-0.24 | $0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | — |
| Total DebtLower is stronger | — | $412.3M |
| Stockholders' EquityBook value | $265.5M | $349.4M |
| Total Assets | $661.9M | $2.3B |
| Debt / EquityLower = less leverage | — | 1.18× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $86.1M | — | ||
| Q2 25 | $123.8M | — | ||
| Q1 25 | $95.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $657.1M | — | ||
| Q2 24 | $705.9M | — | ||
| Q1 24 | $758.5M | — |
| Q4 25 | — | $412.3M | ||
| Q3 25 | — | $469.1M | ||
| Q2 25 | — | $465.7M | ||
| Q1 25 | — | $395.9M | ||
| Q4 24 | — | $446.5M | ||
| Q3 24 | — | $560.1M | ||
| Q2 24 | — | $660.8M | ||
| Q1 24 | — | $634.2M |
| Q4 25 | — | $349.4M | ||
| Q3 25 | $265.5M | $345.5M | ||
| Q2 25 | $346.5M | $341.5M | ||
| Q1 25 | $371.1M | $341.4M | ||
| Q4 24 | — | $339.1M | ||
| Q3 24 | $477.0M | $342.0M | ||
| Q2 24 | $527.8M | $334.9M | ||
| Q1 24 | $582.0M | $338.0M |
| Q4 25 | — | $2.3B | ||
| Q3 25 | $661.9M | $2.3B | ||
| Q2 25 | $721.0M | $2.3B | ||
| Q1 25 | $746.3M | $2.2B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | $827.5M | $2.2B | ||
| Q2 24 | $853.6M | $2.3B | ||
| Q1 24 | $901.4M | $2.2B |
| Q4 25 | — | 1.18× | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 1.36× | ||
| Q1 25 | — | 1.16× | ||
| Q4 24 | — | 1.32× | ||
| Q3 24 | — | 1.64× | ||
| Q2 24 | — | 1.97× | ||
| Q1 24 | — | 1.88× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $24.2M |
| Free Cash FlowOCF − Capex | $-72.3M | $23.0M |
| FCF MarginFCF / Revenue | -341.2% | 61.9% |
| Capex IntensityCapex / Revenue | 20.8% | 3.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $43.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $24.2M | ||
| Q3 25 | $-67.9M | $32.7M | ||
| Q2 25 | $-72.8M | $-38.4M | ||
| Q1 25 | $-75.6M | $26.7M | ||
| Q4 24 | — | $48.1M | ||
| Q3 24 | $-76.7M | $74.1M | ||
| Q2 24 | $-51.1M | $-39.5M | ||
| Q1 24 | $-40.5M | $-9.9M |
| Q4 25 | — | $23.0M | ||
| Q3 25 | $-72.3M | $32.4M | ||
| Q2 25 | $-80.1M | $-38.5M | ||
| Q1 25 | $-83.8M | $26.5M | ||
| Q4 24 | — | $47.0M | ||
| Q3 24 | $-86.3M | $73.9M | ||
| Q2 24 | $-51.9M | $-39.7M | ||
| Q1 24 | $-41.0M | $-10.3M |
| Q4 25 | — | 61.9% | ||
| Q3 25 | -341.2% | 87.5% | ||
| Q2 25 | -382.6% | -101.2% | ||
| Q1 25 | -933.1% | 89.2% | ||
| Q4 24 | — | 147.5% | ||
| Q3 24 | — | 216.9% | ||
| Q2 24 | — | -106.7% | ||
| Q1 24 | -406.8% | -31.9% |
| Q4 25 | — | 3.1% | ||
| Q3 25 | 20.8% | 0.8% | ||
| Q2 25 | 34.8% | 0.2% | ||
| Q1 25 | 91.8% | 0.9% | ||
| Q4 24 | — | 3.5% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | 5.3% | 1.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | 4.13× | ||
| Q2 25 | — | -4.98× | ||
| Q1 25 | — | 8.81× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 15.67× | ||
| Q2 24 | — | -6.92× | ||
| Q1 24 | — | -3.27× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
